Ładuje się......
Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic skin disease characterized by inflammatory lesions that flare unpredictably. The impact of weekly adalimumab (ADAew) on HS flare is not well‐characterized. OBJECTIVE: To evaluate the impact of disease flare on health‐related quality of life (HRQ...
Zapisane w:
| Wydane w: | J Eur Acad Dermatol Venereol |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7318582/ https://ncbi.nlm.nih.gov/pubmed/31630445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.16023 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|